Angela Ibáñez, PhD, is affiliated with the Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM) and the Department of Psychiatry at Hospital Universitario Ramón y Cajal, IRYCIS, Universidad de Alcalá in Madrid, Spain. With publications spanning from 2003 to 2023, her research focuses on addiction, impulse-control disorders, psychotic disorders, and schizophrenia/schizoaffective disorders. Her work includes studies on neighborhood vulnerability in first-episode psychosis, pharmacological treatments for negative symptoms of schizophrenia, and pathological gambling. Frequent collaborators include Carlos Blanco, Roberto Rodriguez-Jimenez, and the AGES-CM Group.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
